Scaling Human Evidence

Pheiron is the evidence layer for drug development — our AI models integrate population-scale, multi-omic, and clinical data to map human health and disease with unprecedented resolution.
Explore research

Causal insights on Human Biology

We are building the Evidence Layer for Drug Development: Our AI-native platform unifies population‑scale human data to construct quantitative, high-resolution representations of human health and disease.

By resolving human phenotypic complexity accurately and precisely, we enable detailed understanding of the architecture of human disease and its progression.

Our platform unlocks a universe of actionable human evidence on disease mechanisms and patient populations to drive next generation therapeutics.

Power reverse translation with AI: We help teams reduce biological risk, assess clinical validity and design translational strategies that maximize clinical success.

Our foundational research

We publish and collaborate at the intersection of genetics, epidemiology, and machine learning. We advance methods that turn population-scale human data into decision‑grade evidence.

Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats
Nature Communications
January 2025
Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Disease Risk: Findings from Real-World Data using AI-Powered Outcomes
In Press
September 2024
The GPS for drug development: navigating with evidence from human populations
Trends in Biotechnology
August 2024
Metabolomic profiles predict individual multidisease outcomes
Nature Medicine
September 2022
more publications

‍

‍

Human Evidence
ResearchTeamCareers
PreferencesLegalPrivacy

Contact us

Message received!
Oops! Something went wrong while submitting the form.
Human Evidence
ResearchTeamCareers
PreferencesLegalPrivacy